Improving the Bioavailability and Efficacy of Coenzyme Q10 on Alzheimer's Disease Through the Arginine Based Proniosomes.

MLA

Ergin, Ahmet Doğan, et al. “Improving the Bioavailability and Efficacy of Coenzyme Q10 on Alzheimer’s Disease Through the Arginine Based Proniosomes.” Journal of Pharmaceutical Sciences, vol. 112, no. 11, Nov. 2023, pp. 2921–32. EBSCOhost, https://doi.org/10.1016/j.xphs.2023.07.020.

APA

Ergin, A. D., Üner, B., Balcı, Ş., Demirbağ, Ç., Benetti, C., & Oltulu, Ç. (2023). Improving the Bioavailability and Efficacy of Coenzyme Q10 on Alzheimer’s Disease Through the Arginine Based Proniosomes. Journal of Pharmaceutical Sciences, 112(11), 2921–2932. https://doi.org/10.1016/j.xphs.2023.07.020

Chicago

Ergin, Ahmet Doğan, Burcu Üner, Şencan Balcı, Çağlar Demirbağ, Camillo Benetti, and Çağatay Oltulu. 2023. “Improving the Bioavailability and Efficacy of Coenzyme Q10 on Alzheimer’s Disease Through the Arginine Based Proniosomes.” Journal of Pharmaceutical Sciences 112 (11): 2921–32. doi:10.1016/j.xphs.2023.07.020.